Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
FERMENTA
₹409.80
₹396.95
₹415.70
Data is not available
Markets Today
Historical Performance
As of 10-07-2026 20:02, Fermenta Biotech Ltd. share price today is ₹0, with a change of ₹-401.10 (-100.00%) from the previous close of ₹401.1. The stock opened at ₹408 and traded between ₹396.95 and ₹415.7, with a total traded volume of 25606 shares. The company has a market capitalization of ₹1180.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹414.95 and ₹256.4, respectively.
Fermenta Biotech Ltd. valuation metrics include a P/E ratio of 16.3, EPS of ₹24.7, and book value of ₹2.90. Profitability indicators show ROE of 17.86% along with a dividend yield of 0.6%. Fermenta Biotech Ltd. has reported revenue of ₹525.43 Cr and net profit of ₹72.58 Cr.
Fermenta Biotech Ltd. technical indicators include Day RSI at 67.55, Day MFI at 79.19, Day ADX at 29.37. Additional indicators include Commodity Channel Index (CCI) at 180.8 and Williams %R at -14.8. Momentum indicators show Day MACD at 15.9, Day MACD Signal Line at 12.77, DayATR at 22.62. Rate of Change indicators for Fermenta Biotech Ltd. include ROC125 at 14.73 and ROC21 at 17.32.
Exponential moving averages include EMA5 at ₹378, EMA10 at ₹367.9, EMA12 at ₹364.8, EMA20 at ₹354.6, EMA26 at ₹348.8, EMA50 at ₹336.4, EMA100 at ₹328.5, EMA200 at ₹323.1. Simple moving averages include SMA5 at ₹375.4, SMA10 at ₹366, SMA20 at ₹350.7, SMA30 at ₹340, SMA50 at ₹323, SMA100 at ₹325.8, SMA150 at ₹325.7, SMA200 at ₹317.7.
Support levels for Fermenta Biotech are placed at First Support ₹379.08, Second Support ₹357.07, Third Support ₹339.13. Resistance levels are seen at First Resistance ₹419.03, Second Resistance ₹436.97, Third Resistance ₹458.98. Fermenta Biotech Ltd. shareholding pattern shows promoter holding at 64.09%, FII holding at 0.02%, DII holding at 0%, public holding at 33.32%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 109.88 | 114.24 | 107.12 | 119.02 | 122.04 |
| Operating Expense | 88.04 | 90.78 | 84.15 | 96.49 | 89.36 |
| Operating Profit | 21.84 | 23.46 | 22.97 | 22.53 | 32.67 |
| Depreciation | 5.08 | 5.17 | 5.13 | 5.55 | 5.60 |
| Interest | 2.77 | 3.03 | 2.59 | 3.10 | 2.99 |
| Tax | 7.59 | 4.83 | 6.05 | 6.49 | -1.34 |
| Net Profit | 21.57 | 11.76 | 14.72 | 16.23 | 29.31 |
₹409.80
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 62.1 | 64.1 | 64.1 | 64.1 | 64.1 | 64.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 37 | 35 | 35 | 34.8 | 34 | 33.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.05 L | 23.1 L | 13.20% |
| Week | 1.87 L | 12.74 L | 14.64% |
| 1 Month | 82.67 K | 3.77 L | 21.90% |
| 6 Month | 27.73 K | 84.85 K | 32.68% |
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Affordable Stocks with High ROE and Momentum
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
New 52 Week High
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 06 Aug, 2025 | 2.5 | FINAL | 06 Aug, 2025 | Equity Share |
| 06 Aug, 2024 | 1.25 | FINAL | 06 Aug, 2024 | Equity Share |
| 22 Sep, 2023 | 1.25 | FINAL | 22 Sep, 2023 | Equity Share |
| 04 Aug, 2022 | 1.25 | FINAL | 05 Aug, 2022 | Equity Share |
| 25 Aug, 2021 | 2.5 | FINAL | Equity Share | |
| 22 Nov, 2019 | 5 | INTERIM | 25 Nov, 2019 | Equity Share |
| 28 Jun, 2019 | 1.25 | FINAL | Equity Share | |
| 19 Sep, 2018 | 1.25 | FINAL | Equity Share | |
| 21 Sep, 2017 | 2.5 | FINAL | Equity Share | |
| 19 Sep, 2016 | 2.5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹41 | ₹587.60 | ₹183.50 | ₹259.30 | ₹35 | ₹5.40 |
| % Change | 0.00% | -1.43% | -0.27% | 0.00% | -2.78% | -0.18% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-34.95 |
| PE TTM | 9.60 | - | 12.40 | 37.00 | -85.20 | -1.30 |
| 1 Year Return | 52.07 | 700 | 441 | |||
| ROCE | - | 3.56 | - | - | - | -5.63 |
Aptus Pharma Ltd.
₹ 224.00
+1.93%
Amanta Healthcare Ltd.
₹ 179.17
-2.00%
Anlon Healthcare Ltd.
₹ 15.60
+0.84%
Patel Chem Specialities Ltd.
₹ 95.00
-1.04%
Asston Pharmaceuticals Ltd.
₹ 76.50
+1.32%
Amrutanjan Health Care Ltd.
₹ 535.00
-0.10%
Astonea Labs Ltd.
₹ 282.55
+1.99%
Amwill Health Care Ltd.
₹ 41.00
-3.91%
Valiant Laboratories Ltd.
₹ 62.00
-0.26%
Shelter Pharma Ltd.
₹ 27.40
+6.41%
Trident Lifeline Ltd.
₹ 262.50
-0.61%
Dipna Pharmachem Ltd.
₹ 5.76
-8.86%
Achyut Healthcare Ltd.
₹ 8.20
+0.12%
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Chandra Bhagat Pharma Ltd.
₹ 38.55
-4.98%
Cian Healthcare Ltd.
₹ 8.67
+0.00%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Rajnish Wellness Ltd.
₹ 0.41
+0.00%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Bharat Parenterals Ltd.
₹ 1402.00
-0.61%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Shree Ganesh Remedies Ltd.
₹ 687.00
+1.43%
By signing up I certify terms, conditions & privacy policy